Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: love this statement

love this statement

posted on Dec 21, 2007 04:04AM
“This agreement is in the best interests of Verigy, its shareholders and customers because it removes the possibility of supply chain disruptions,” said Mike Davis, Senior Vice President, Licensing for Alliacense.
Share
New Message
Please login to post a reply